Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Marimed (MRMD) Revenue (2016 - 2025)

Historic Revenue for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $40.8 million.

  • Marimed's Revenue rose 41.63% to $40.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.5 million, marking a year-over-year decrease of 20.97%. This contributed to the annual value of $158.0 million for FY2024, which is 630.29% up from last year.
  • Marimed's Revenue amounted to $40.8 million in Q3 2025, which was up 41.63% from $39.6 million recorded in Q2 2025.
  • Marimed's Revenue's 5-year high stood at $40.8 million during Q3 2025, with a 5-year trough of $24.6 million in Q1 2021.
  • Over the past 5 years, Marimed's median Revenue value was $36.5 million (recorded in 2023), while the average stood at $35.8 million.
  • Its Revenue has fluctuated over the past 5 years, first surged by 23889.66% in 2021, then plummeted by 204.51% in 2025.
  • Over the past 5 years, Marimed's Revenue (Quarter) stood at $31.0 million in 2021, then grew by 15.42% to $35.8 million in 2022, then grew by 8.57% to $38.9 million in 2023, then increased by 0.78% to $39.2 million in 2024, then increased by 3.98% to $40.8 million in 2025.
  • Its Revenue stands at $40.8 million for Q3 2025, versus $39.6 million for Q2 2025 and $38.0 million for Q1 2025.